Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Fuman Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Xiamen, Fujian Province, specializing in the research, development, and production of chemical drugs and Traditional Chinese Medicine (TCM). Established in 2003, the company operates a manufacturing facility in the Haicang District that complies with national Good Manufacturing Practice (GMP) standards. Its product portfolio includes a variety of oral solid dosage forms such as tablets, capsules, and granules, marketed under the 'Fuman' brand. The company's therapeutic focus spans infectious diseases, respiratory health, and gastroenterology, providing essential medicines to the domestic Chinese market. Xiamen Fuman Pharmaceutical is recognized as a high-tech enterprise and emphasizes the integration of modern pharmaceutical technology with traditional herbal medicine. The firm plays a key role in the regional healthcare industry by ensuring the supply of high-quality generic and traditional treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Fuman Pharmaceutical.